A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are paired with a therapeutic component, according to a study published in Cell in October.
(PRWeb October 29, 2020)
Read the full story at https://www.prweb.com/releases/scientists_engineer_new_cancer_immunotherapy_to_train_immune_system_in_cancer_fight/prweb17512027.htm
For more information, please visit
https://www.prweb.com/releases/scientist[...]cancer_fight/prweb17512027.htm